| 000072 (2000) |
N. J. Cox [États-Unis] ; K. Subbarao [États-Unis] | Global epidemiology of influenza : Past and present |
| 000084 (1997) |
T. Utsunomiya [États-Unis] ; M. Kobayashi [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis] | Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus |
| 000129 (1985) |
R. Pyhala | Antibody status to influenza A/Singapore/1/57(H2N2) in Finland during a period of outbreaks caused by H3N2 and H1N1 subtype viruses |
| 000131 (1984) |
W. G. Laver ; R. G. Webster ; C. M. Chu | Summary of a meeting on the origin of pandemic influenza viruses |
| 000033 (2008) |
Andrew D. Cliff [Royaume-Uni] ; Peter Haggett [Royaume-Uni] ; Matthew Smallman-Raynor [Royaume-Uni] | An exploratory method for estimating the changing speed of epidemic waves from historical data : Communicable disease |
| 000036 (2007) |
Alison Budd [Australie] ; Lisa Alleva [Australie] ; Mohammed Alsharifi [Australie] ; Aulikki Koskinen [Australie] ; Victoria Smythe [Australie] ; Arno Müllbacher [Australie] ; Jeff Wood [Australie] ; Ian Clark [Australie] | Increased survival after gemfibrozil treatment of severe mouse influenza |
| 000053 (2004) |
Thomas A. Reichert [États-Unis] ; Lone Simonsen [États-Unis] ; Ashutosh Sharma [États-Unis] ; Scott A. Pardo [France] ; David S. Fedson [France] ; Mark A. Miller [États-Unis] | Influenza and the winter increase in mortality in the United States, 1959-1999 |
| 000058 (2003) |
Nancy J. Cox [États-Unis] ; Susan E. Tamblyn [Canada] ; Theresa Tam [Canada] | Influenza pandemic planning |
| 000064 (2002) |
Ilaria Capua [Italie] ; Dennis J. Alexander [Royaume-Uni] | Avian influenza and human health |
| 000065 (2002) |
A. R. Rekstin ; A. N. Naikhin ; I. B. Barantseva ; L. G. Rudenko | En Russe |
| 000075 (1999) |
M. Kobayashi [États-Unis] ; S. M. Davis [États-Unis] ; T. Utsunomiya [États-Unis] ; R. B. Pollard [États-Unis] ; F. Suzuki [États-Unis] | Antiviral effect of gingyo-san, a traditional chinese herbal medicine, on influenza A2 virus infection in mice |
| 000077 (1998) |
K. Sato [Japon] ; M. Suga [Japon] ; T. Akaike [Japon] ; S. Fujii [Japon] ; H. Muranaka [Japon] ; T. Doi [Japon] ; H. Maeda [Japon] ; M. Ando [Japon] | Therapeutic effect of erythromycin on influenza virus-induced lung injury in mice |
| 000078 (1998) |
L. Simonsen [États-Unis] ; M. J. Clarke [États-Unis] ; L. B. Schonberger [États-Unis] ; N. H. Arden [États-Unis] ; N. J. Cox [États-Unis] ; K. Fukuda [États-Unis] | Pandemic versus epidemic influenza mortality : A pattern of changing age distribution |
| 000081 (1998) |
S. Sambhara [Canada, Suède] ; S. Woods ; R. Arpino ; A. Kurichh ; A. Tamane ; B. Underdown ; M. Klein ; K. L. Bengtsson ; B. Morein ; D. Burt | Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes |
| 000083 (1997) |
E. D. Kilbourne [États-Unis] | Perspectives on pandemics : A research agenda |
| 000094 (1994) |
WUXIONG CAO [États-Unis] ; B. A. Myers-Powell ; T. J. Braciale | Recognition of an immunoglobulin VH epitope by influenza virus-specific class I major histocompatibility complex-restricted cytolytic T lymphocytes |
| 000098 (1993) |
J. R. Sch Fer [États-Unis] ; Yoshihiro Kawaoka [États-Unis] ; W. J. Bean [États-Unis] ; J. Süss ; D. Senne ; R. G. Webster [États-Unis] | Origin of the pandemic 1957 H2 influenza A viruses and the persistence of its possible progenitors in the avian reservoir |
| 000111 (1990) |
G. N. Milligan [États-Unis] ; L. A. Morrison [États-Unis] ; J. Gorka ; V. L. Braciale [États-Unis] ; T. J. Braciale [États-Unis] | The recognition of a viral antigenic moiety by class I MHC-restricted cytolytic T lymphocytes is limited by the availability of the endogenously processed antigen |
| 000003 (2012) |
JIANZHONG SHI [République populaire de Chine] ; ZHIYUAN WEN [République populaire de Chine] ; JING GUO [République populaire de Chine] ; YING ZHANG [République populaire de Chine] ; GUOHUA DENG [République populaire de Chine] ; YUELONG SHU [République populaire de Chine] ; DAYAN WANG [République populaire de Chine] ; YONGPING JIANG [République populaire de Chine] ; Yoshihiro Kawaoka [Japon] ; ZHIGAO BU [République populaire de Chine] ; HUALAN CHEN [République populaire de Chine] | Protective efficacy of an H1N1 cold-adapted live vaccine against the 2009 pandemic H1N1, seasonal H1N1, and H5N1 influenza viruses in mice |
| 000004 (2012) |
Jens C. Krause [États-Unis] ; Tshidi Tsibane [États-Unis] ; Terrence M. Tumpey [États-Unis] ; Chelsey J. Huffman [États-Unis] ; Randy Albrecht [États-Unis] ; David L. Blum [États-Unis] ; Irene Ramos [États-Unis] ; Ana Fernandez-Sesma [États-Unis] ; Kathryn M. Edwards [États-Unis] ; Adolfo Garcia-Sastre [États-Unis] ; Christopher F. Basler [États-Unis] ; James E. Jr Crowe [États-Unis] | Human Monoclonal Antibodies to Pandemic 1957 H2N2 and Pandemic 1968 H3N2 Influenza Viruses |
| 000007 (2012) |
Jenny Aurielle B. Babon [États-Unis] ; John Cruz [États-Unis] ; Francis A. Ennis [États-Unis] ; LIUSONG YIN [États-Unis] ; Masanori Terajima [États-Unis] | A Human CD4+ T Cell Epitope in the Influenza Hemagglutinin Is Cross-Reactive to Influenza A Virus Subtypes and to Influenza B Virus |
| 000016 (2010) |
Jeff Alexander [États-Unis] ; Pamuk Bilsel [États-Unis] ; Marie-France Del Guercio [États-Unis] ; Stephani Stewart [États-Unis] ; Aleksandra Marinkovic-Petrovic [États-Unis] ; Scott Southwood [États-Unis] ; Claire Crimi [États-Unis] ; Lo Vang [États-Unis] ; Les Walker [États-Unis] ; Glenn Ishioka [États-Unis] ; Vivek Chitnis [États-Unis] ; Alessandro Sette [États-Unis] ; Erika Assarsson [États-Unis] ; Drew Hannaman [États-Unis] ; Jason Botten [États-Unis] ; Markj. Newman [États-Unis] | Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice |
| 000021 (2010) |
Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; Chin-Fen Yang [États-Unis] ; HONG JIN [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | Evaluation of Replication and Cross-Reactive Antibody Responses of H2 Subtype Influenza Viruses in Mice and Ferrets |
| 000022 (2010) |
Alicia Solorzano [États-Unis] ; JIANQIANG YE [États-Unis] ; Daniel R. Perez [États-Unis] | Alternative Live-Attenuated Influenza Vaccines Based on Modifications in the Polymerase Genes Protect against Epidemic and Pandemic Flu |
| 000025 (2009) |
Leo L. M. Poon [Hong Kong] ; K. H. Chan [Hong Kong] ; G. J. Smith [Hong Kong] ; C. S. W. Leung [Hong Kong] ; Y. Guan [Hong Kong] ; K. Y. Yuen [Hong Kong] ; J. S. M. Peiris [Hong Kong] | Molecular Detection of a Novel Human Influenza (H1N1) of Pandemic Potential by Conventional and Real-Time Quantitative RT-PCR Assays |
| 000038 (2007) |
JAE MIN SONG [Corée du Sud] ; KI DUK PARK [Corée du Sud] ; KWANG HEE LEE [Corée du Sud] ; YOUNG HO BYUN [Corée du Sud] ; JU HEE PARK [Corée du Sud] ; SUNG HAN KIM [Corée du Sud] ; JAE HONG KIM [Corée du Sud] ; BAIK LIN SEONG [Corée du Sud] | Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives |
| 000049 (2005) |
Colin R. Parrish [États-Unis] ; Yoshihiro Kawaoka [États-Unis, Japon] | The origins of new pandemic viruses: The acquisition of new host ranges by canine parvovirus and influenza A viruses |
| 000055 (2004) |
I. Kiseleva [États-Unis, Russie] ; Q. Su [États-Unis] ; T. J. Toner [États-Unis] ; C. Szymkowiak [États-Unis] ; W.-S. Kwan [États-Unis] ; L. Rudenko [Russie] ; A. R. Shaw [États-Unis] ; R. Youil [États-Unis] | Cell-based assay for the determination of temperature sensitive and cold adapted phenotypes of influenza viruses |
| 000059 (2003) |
H. Chen [États-Unis] ; Y. Matsuoka [États-Unis] ; David Swayne [États-Unis] ; Q. Chen [États-Unis] ; N. J. Cox [États-Unis] ; B. R. Murphy [États-Unis] ; K. Subbarao [États-Unis] | Generation and characterization of a cold-adapted influenza A H9N2 reassortant as a live pandemic influenza virus vaccine candidate |
| 000062 (2002) |
Jeffrey J. Landers [États-Unis] ; ZHENGYI CAO [États-Unis] ; INHAN LEE [États-Unis] ; Lars T. Piehler [États-Unis] ; Piotr P. Myc [États-Unis] ; Andrzej Myc [États-Unis] ; Tarek Hamouda [États-Unis] ; Andrzej T. Galecki [États-Unis] ; James R. Jr Baker [États-Unis] | Prevention of influenza pneumonitis by sialic acid-conjugated dendritic polymers |
| 000091 (1995) |
D. Cotter [Irlande (pays)] ; N. Takei ; M. Farrell ; PAK SHAM ; P. Quinn ; C. Larkin [Irlande (pays)] ; J. Oxford ; R. M. Murray ; E. O'Callaghan [Irlande (pays)] | Does prenatal exposure to influenza in mice induce pyramidal cell disarray in the dorsal hippocampus ? |
| 000124 (1986) |
T. Sonoguchi ; M. Sakoh ; N. Kunita ; K. Satsuta ; H. Noriki ; H. Fukumi | Reinfection with influenza A (H2N2, H3N2, and H1N1) viruses in soldiers and students in Japan |
| 000126 (1985) |
D. B. Golubev ; G. I. Karpukhin ; S. S. Galitarov ; G. M. Denisov | Type A influenza (H2N2) viruses isolated in Leningrad in 1980 |
| 000000 (2013) |
Alexandru Coman [Roumanie] ; Daniel N. Maftei [Roumanie] ; Whitney S. Krueger [États-Unis] ; Gary L. Heilb [États-Unis] ; John A. Friary [États-Unis] ; Razvan M. Chereches [Roumanie] ; Emanuela Sirlincan [Roumanie] ; Paul Bria [Roumanie] ; Claudiu Dragnea [Roumanie] ; Losif Kasler [Roumanie] ; Gregory C. Gray [États-Unis] | Serological evidence for avian H9N2 influenza virus infections among Romanian agriculture workers |
| 000001 (2013) |
M. E. Arnold [Royaume-Uni] ; M. J. Slomka [Royaume-Uni] ; V. J. Coward [Royaume-Uni] ; S. Mahmood [Royaume-Uni] ; P. J. Raleigh [Irlande (pays)] ; I. H. Brown [Royaume-Uni] | Evaluation of the pooling of swabs for real-time PCR detection of low titre shedding of low pathogenicity avian influenza in turkeys |
| 000002 (2013) |
Takayuki Komatsu [Japon] ; Nobuo Kido [Japon] ; Tsuyoshi Sugiyama [Japon] ; Takashi Yokochi [Japon] | Antiviral activity of acidic polysaccharides from Coccomyxa gloeobotrydiformi, a green alga, against an in vitro human influenza A virus infection |
| 000006 (2012) |
CHAO QIU [République populaire de Chine] ; YANG HUANG [République populaire de Chine] ; QIAN WANG [République populaire de Chine] ; DI TIAN [République populaire de Chine] ; WANJU ZHANG [République populaire de Chine] ; YUNWEN HU [République populaire de Chine] ; ZHENGHONG YUAN [République populaire de Chine] ; XIAOYAN ZHANG [République populaire de Chine] ; JIANQING XU [République populaire de Chine] | Boosting Heterosubtypic Neutralization Antibodies in Recipients of 2009 Pandemic H1N1 Influenza Vaccine |
| 000010 (2011) |
Nobuko Ohshima [Japon] ; Yoshitaka Iba [Japon] ; Ritsuko Kubota-Koketsu [Japon] ; Yoshizo Asano [Japon] ; Yoshinobu Okuno [Japon] ; Yoshikazu Kurosawa [Japon] | Naturally Occurring Antibodies in Humans Can Neutralize a Variety of Influenza Virus Strains, Including H3, H1, H2, and H5 |
| 000017 (2010) |
RUI XU [États-Unis] ; Ryan Mcbride [États-Unis] ; James C. Paulson [États-Unis] ; Christopher F. Basler [États-Unis] ; Ian A. Wilson [États-Unis] | Structure, Receptor Binding, and Antigenicity of Influenza Virus Hemagglutinins from the 1957 H2N2 Pandemic |
| 000018 (2010) |
J. Theo [Pays-Bas] ; M. Voeten [Pays-Bas] ; Irina V. Kiseleva [Russie] ; Harrie L. Glansbeek [Pays-Bas] ; Stephanie M. C. Basten [Pays-Bas] ; Sandra K. M. Drieszen-Van Der Cruijsen [Pays-Bas] ; Larisa G. Rudenko [Russie] ; Han Van Den Bosch [Pays-Bas] ; Jacco G. M. Heldens [Pays-Bas] | Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model |
| 000023 (2010) |
Ji-Young Min [États-Unis] ; Leatrice Vogel [États-Unis] ; Yumiko Matsuoka [États-Unis] ; BIN LU [États-Unis] ; David Swayne [États-Unis] ; HONG JIN [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | A Live Attenuated H7N7 Candidate Vaccine Virus Induces Neutralizing Antibody That Confers Protection from Challenge in Mice, Ferrets, and Monkeys |
| 000026 (2009) |
Jennifer Uhlendorff [Allemagne] ; Tatyana Matrosovich [Allemagne] ; Hans-Dieter Klenk [Allemagne] ; Mikhail Matrosovich [Allemagne] | Functional significance of the hemadsorption activity of influenza virus neuraminidase and its alteration in pandemic viruses |
| 000027 (2009) |
Irina A. Leneva [Royaume-Uni, Russie] ; Rupert J. Russell [Royaume-Uni] ; Yury S. Boriskin [Russie] ; Alan J. Hay [Royaume-Uni] | Characteristics of arbidol-resistant mutants of influenza virus : Implications for the mechanism of anti-influenza action of arbidol |
| 000028 (2009) |
Kawsar R. Talaat [États-Unis] ; Ruth A. Karron [États-Unis] ; Karen A. Callahan [États-Unis] ; Catherine J. Luke [États-Unis] ; Susan C. Dilorenzo [États-Unis] ; Grace L. Chen [États-Unis] ; Elaine W. Lamirande [États-Unis] ; HONG JIN [États-Unis] ; Kathy L. Coelingh [États-Unis] ; Brian R. Murphy [États-Unis] ; George Kemble [États-Unis] ; Kanta Subbarao [États-Unis] | A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults |
| 000029 (2008) |
Nigel J. Dimmock [Royaume-Uni] ; Edward W. Rainsford [Royaume-Uni] ; Paul D. Scott [Royaume-Uni] ; Anthony C. Marriott [Royaume-Uni] | Influenza Virus Protecting RNA : an Effective Prophylactic and Therapeutic Antiviral |
| 000031 (2008) |
David S. Fedson | Confronting an influenza pandemic with inexpensive generic agents : can it be done? |
| 000034 (2007) |
E. N. Prokudina [Russie] ; N. P. Semenova [Russie] ; V. M. Chumakov [Russie] ; T. A. Grigorieva [Russie] | Non-compact nucleocapsid protein multimers in influenza-virus-infected cells |
| 000040 (2006) |
Edwin D. Kilbourne [États-Unis] ; Suzanne L. Epstein [États-Unis] | Prior H1N1 influenza infection and susceptibility of cleveland family study participants during the H2N2 pandemic of 1957 : An experiment of nature. Commentary |
| 000043 (2006) |
Insung Ahn [Corée du Sud] ; Byeong-Jin Jeone [Corée du Sud] ; Se-Eun Bae [Corée du Sud] ; Jin Jung [Corée du Sud] ; Hveon S. Son [Corée du Sud] | Genomic analysis of influenza A viruses, including avian Flu (H5N1) strains |
| 000047 (2006) |
D. J. Alexander [Royaume-Uni] | Avian influenza viruses and human health |
| 000048 (2006) |
Samson S. Y. Wong [Hong Kong] ; Kwok-Yung Yuen [Hong Kong] | Avian influenza virus infections in humans |
| 000051 (2005) |
Mark D. Wareing [Australie] ; Leonard C. Harrison [Australie] ; Gregory A. Tannock [Australie] | Pulmonary CD4+ cytokine responses in mice reveal differences in the relative immunogenicity of cold-adapted influenza A vaccine donor strains |
| 000063 (2002) |
W. E. P. Beyer [Pays-Bas] ; A. M. Palache [Pays-Bas] ; J. C. De Jong [Pays-Bas] ; A. D. M. E. Osterhaus [Pays-Bas] | Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy A meta-analysis |
| 000067 (2002) |
E. P. Grigoryeva ; Ya. A. Desheva ; S. A. Donina ; A. N. Naikhin ; A. R. Rekstin ; I. B. Barantseva ; E. A. Zavitkova ; T. M. Moskvichyova ; V. G. Zhavoronkov ; L. G. Rudenko | En Russe |
| 000068 (2002) |
Yu. A. Desheva ; G. V. Danini ; E. P. Grigoryeva ; S. A. Donina ; I. V. Kiseleva ; A. R. Rekstin ; L. A. Ermakova ; V. K. Natsina ; V. M. Nikolaeva ; N. I. Lonskaya ; G. A. Elshina ; V. G. Zhavoronkov ; V. P. Drinevsky ; M. K. Erofeeva ; A. N. Naikhin ; L. G. Rudenko | En Russe |
| 000076 (1998) |
D. Miyamoto [Japon] ; Y. Kusagaya [Japon] ; N. Endo [Japon] ; A. Sometani [Japon] ; S. Takeo [Japon] ; T. Suzuki [Japon] ; Y. Arima [Japon] ; K. Nakajima [États-Unis] ; Y. Suzuki [Japon] | Thujaplicin-copper chelates inhibit replication of human influenza viruses |
| 000079 (1998) |
A. Natali [Italie] ; E. Pilotti [Italie] ; P. P. Valcavi [Italie] ; C. Chezzi [Italie] ; J. S. Oxford [Royaume-Uni] | Natural and 'in vitro' selected antigenic variants of influenza a virus (H2N2) |
| 000086 (1996) |
K. G. Nicholson [Royaume-Uni] | Use of antivirals in influenza in the elderly : Prophylaxis and therapy |
| 000088 (1996) |
S. Sakamoto [Japon] ; Y. Kino [Japon] ; T. Oka [Japon] ; M. L. Herlocher ; H. F. Maasab | Gene analysis of reassortant influenza virus by RT-PCR followed by restriction enzyme digestion |
| 000090 (1995) |
G. A. Tannock [Australie] ; J. R. Romanova ; J. A. Paul | The immunogenicity of reassortants of the cold-adapted influenza A master strain A/Ann Arbor/6/60 is determined by both the genes for cold-adaptation and the haemagglutinin gene |
| 000092 (1994) |
M. A. Ball [États-Unis] ; T. Utsunomiya ; K. Ikemoto ; M. Kobayashi ; R. B. Pollard ; F. Suzuki | The antiviral effect of Keishi-ni-eppi-ichi-to, a traditional Chinese herbal medicine, on influenza A2(H2N2) virus infection in mice |
| 000093 (1994) |
M. Tamura [États-Unis] ; R. G. Webster ; F. A. Ennis [États-Unis] | Subtype cross-reactive, infection-enhancing antibody responses to influenza A viruses |
| 000097 (1993) |
T. E. Medvedeva [Russie] ; V. K. Kudryavtseva ; G. N. Nevedomskaya ; I. V. Zhikhareva ; M. I. Gushchina ; F. N. Zolotarev ; G. M. Vodeiko ; K. V. Lisovskaya ; V. V. Iotov ; M. I. Khaider ; V. V. Yarosh ; A. I. Klimov ; G. I. Aleksandrova | Role of individual genes in expression of phenotypic properties of the cold-adapted strain A/leningrad/134/47/57 (H2N2), a donor for attenuation of living influenza vaccines |
| 000101 (1993) |
H. Nakao [Japon] ; K. Nakajima [Japon] ; S. Nakajima | Location on the evolutionary trees of the non-structural protein (NS) and neuraminidase (NA) genes of late human influenza A (H3N2) viruses : parental viruses of the NS and NA genes of Hong Kong influenza A (H3N2) viruses |
| 000110 (1990) |
I. N. Mbawuike ; H. R. Six ; T. R. Cate ; R. B. Couch | Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes |
| 000114 (1988) |
S. Rochkind ; M. Nissan ; R. Lubart ; J. Avram ; A. Bartal | The in-vivo-nerve response to direct low-energy-laser irradiation |
| 000121 (1987) |
G. A. Tannock ; J. A. Paul | Homotypic and heterotypic immunity of influenza A viruses induced by recombinants of the cold-adapted master strain A/Ann Arbor/6/60-ca |
| 000125 (1986) |
J. R. Bennink ; J. W. Yewdell ; G. L. Smith ; B. Moss | Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes |
| 000132 (1984) |
K. Nerome ; Y. Yoshioka ; C. A. Torres ; A. Oya ; P. Bachmann ; K. Ottis ; WEBSTER | Persistence of Q strain of H2N2 influenzavirus in avian species: antigenic, biological and genetic analysis of avian and human H2N2 viruses |
| 000134 (1984) |
R. B. Belshe ; L. P. Van Voris ; J. Bartram ; F. K. Crookshanks | Live attenuated influenza A virus vaccines in children: results of a field trial |
| 000139 (1983) |
F. I. Polezhaev ; G. N. Budilovskij ; L. M. Garmashova ; Yu. R. Romejko-Gurko ; A. Yu. Egorov ; N. V. Topuriya ; T. A. Koval ; G. I. Aleksandrova | |
